Skye Bioscience
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $13,547,550.

Profit Margin

Skye Bioscience, Inc. (OTC:SKYE): Profit margin
2014 0 -2.73M
2015 0 -4.84M
2016 0 -3.17M
2017 0 -3.09M
2018 0 -19.19M
2019 0 1.05M
2020 0 -6.56M
2021 0 -8.52M
2022 0 -19.48M
2023 0 -37.64M

SKYE Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0000000000
Cost of revenue
124.25K114.99K34.13K1.87K1.46K08.03K09.95K0
Gross profit
-124.25K-114.99K-34.13K-1.87K-1.46K0-8.03K0-9.95K0
Operating exp.
Research and development
5.81M6.01M2.93M1.94M2.23M329.96K311.30K939.04K576.09K227.5K
Selling and marketing
-124.25K000000000
Total operating expenses
13.54M12.10M7.84M6.28M6.63M4.69M3.85M4.47M4.31M2.73M
Operating income
-13.67M-18.31M-7.84M-6.28M-6.63M-4.69M-3.85M-4.47M-4.31M-2.73M
Other income (expenses), net
-23.96M-1.16M-672.36K-270.08K7.68M-14.26M766.53K1.29M-522.33K0
Income before tax
-37.64M-19.47M-8.52M-6.55M1.05M-19.19M-3.09M-3.17M-4.83M-2.73M
Income tax expense
3.6K6.74K2.1K1.6K1.6K1.64K1.6K1.6K1.71K2.50K
Net income
-37.64M-19.48M-8.52M-6.56M1.05M-19.19M-3.09M-3.17M-4.84M-2.73M
Earnings per share
Basic EPS
-5.37-9.82-5.24-6.391.98-36.51-25.62-0.17-71.45-65.08
Diluted EPS
-5.37-9.82-5.15-6.391.98-36.51-25.62-0.17-70.93-65.08
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source